News

Foundation Capital led the round and was joined by Lanza techVentures, both existing investors. Guido Lanza, president and CEO of Numerate, said: “This investment will help support our

Spectrum Pharmaceuticals, a biopharmaceutical company, has announced the closing of the transaction whereby Spectrum acquired 100% control of RIT Oncology to commercialize Zevalin in the US. In connection

Healthpoint, an affiliate of DFB Pharmaceuticals, a specialty pharmaceutical company, has initiated a Phase II clinical trial investigating the efficacy of HP802-247 in venous leg ulcers. HP802-247 is

Innocoll, a biopharmaceutical company, has reported that the last patient has been dosed in the first of two ongoing US Phase III clinical trials sponsored by its wholly

According to OrSense, the NBM-200MP system offers for the first time a non-invasive, continuous and accurate measurement of oxygen saturation in states of hypovolemia, hypothermia and vasoconstriction or

The validity of the German patent is being challenged by Medela, Molnlycke Health Care, and Smith & Nephew. The decision is not final and KCI and Wake Forest

According to Flexible Stenting Solutions, this next-generation femoropopliteal stent and delivery system can significantly improve patient care in the high growth peripheral vascular segment. The fully connected flexible

Durect, a specialty pharmaceutical company, has announced positive results from a 74 patient Phase IIb clinical trial conducted by Endo Pharmaceuticals of Transdur-sufentanil, a seven day patch under

Shire, a specialty biopharmaceutical company, has decided to withdraw the European marketing authorization application for Daytrana for the treatment of attention deficit hyperactivity disorder. A request from European